Skip to main content
Global Bioenergies logo

Global Bioenergies — Investor Relations & Filings

Ticker · ALGBE ISIN · FR0011052257 LEI · 969500H46XRAMTMVB676 PA Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2014-03-24 Regulatory Filings
Country FR France
Listing PA ALGBE

About Global Bioenergies

https://www.global-bioenergies.com/?lan…

Global Bioenergies develops and commercializes a process to convert renewable resources, such as plant-based sugars and agricultural waste, into isobutene. The company's proprietary technology utilizes fermentation and synthetic biology to produce this key hydrocarbon, which serves as a platform molecule for various applications. The bio-isobutene can be converted into ingredients for the cosmetics industry, specialty chemicals, and renewable fuels. A primary strategic focus is the production of Sustainable Aviation Fuel (SAF) to support the decarbonization of the aviation sector. The process provides a bio-based alternative to petroleum-derived hydrocarbons, aiming to reduce CO2 emissions and dependence on fossil fuels.

Recent filings

Filing Released Lang Actions
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 88% confidence The document is a press release dated March 24th, 2014, announcing that the Australian Intellectual Property Office has granted two patents protecting key steps in Global Bioenergies' process for converting renewable resources into isobutene. The content focuses entirely on intellectual property protection, patent grants, and the scientific/technological lead this provides. This subject matter (patents and IP rights) does not fit neatly into standard financial reports (10-K, IR, ER) or corporate governance documents (DEF 14A, CGR). It is a specific announcement regarding legal/proprietary assets. Among the provided codes, 'LTR' (Legal Proceedings Report) is the closest fit as it covers legal matters, although patents are generally considered IP rather than litigation. However, given the options, and recognizing that this is a specific announcement about proprietary rights rather than a general regulatory filing (RNS) or a standard business update, 'LTR' is the most appropriate category for significant legal/IP milestones that aren't covered elsewhere. Since the document is a direct announcement of a legal/IP event, and not a general regulatory filing, I will classify it as LTR, though IP is a niche area. Given the strong focus on patents, it is a specific legal/proprietary update.
2014-03-24 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Investor Presentation Classification · 95% confidence The document is a press release dated March 24, 2014, announcing that the Australian Intellectual Property Office has granted two key patents covering steps in Global Bioenergies' process for converting renewable resources into isobutene. The content focuses entirely on intellectual property protection, patent grants, and the strategic implications for their technology. This type of announcement, which details specific legal/IP achievements rather than financial results (ER, IR), management changes (MANG), or general regulatory compliance (RNS), fits best under a category related to specific corporate actions or legal matters. Since there is no specific 'Intellectual Property Filing' code, and it is not a standard financial report, legal proceeding (LTR), or capital action (CAP), it is classified as a general Regulatory Filing (RNS) as it is a formal announcement of a significant corporate event that doesn't fit the other specific categories. Given the short length (3605 chars) and the nature of the announcement (a specific update), RNS is the most appropriate fallback.
2014-03-24 French
Global Bioenergies beauftragt Linde Group mit der Planung der deutschen Pilotanlage
Regulatory Filings Classification · 100% confidence The document is a news release dated March 5, 2014, originating from Global Bioenergies S.A., flagged with 'DGAP-News'. It announces a specific business development: commissioning Linde Group to plan a pilot plant. This is not a full financial report (like 10-K or IR), nor is it a standard earnings release (ER) or a formal regulatory filing like a Director's Dealing or Major Shareholding notification. It is a general corporate announcement regarding a strategic partnership/project milestone. Since it is a news item about corporate activity that doesn't fit the highly specific categories (like M&A, Capital Change, or Dividend), the most appropriate general category is Regulatory Filings (RNS), which serves as the fallback for miscellaneous corporate news releases distributed via regulatory channels (DGAP). The length (5869 chars) is substantial enough that it's not just a brief announcement of a report (RPA).
2014-03-05 German
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 95% confidence The document is a press release dated March 5th, 2014, announcing a specific business development: Global Bioenergies awarding the design contract for its German pilot plant to The Linde Group. It details a partnership and quotes executives. This type of announcement, focusing on strategic business relationships, engineering contracts, or specific operational milestones that are not core financial results (ER/IR) or mandatory regulatory filings (10-K/DEF 14A), typically falls under general corporate news or regulatory filings. Since it is a specific announcement about a major operational step (securing engineering for a pilot plant) and doesn't fit the definitions for M&A (TAR), Capital (CAP), or Director's Dealing (DIRS), the most appropriate category is Regulatory Filings (RNS) as a general announcement, or potentially a specialized announcement if one existed. Given the options, RNS serves as the best fit for a non-standard, material corporate announcement that isn't a standard financial report or governance document. It is not an Earnings Release (ER), Interim Report (IR), or a presentation (IP).
2014-03-05 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated March 5, 2014, announcing a partnership between Global Bioenergies and The Linde Group regarding the design of an industrial pilot plant in Germany. It details business developments, strategic partnerships (with Linde, Audi), and technological progress (isobutene production). This type of announcement, focusing on significant operational or strategic agreements rather than routine financial reporting (like 10-K, ER, or IR), often falls under general corporate news or regulatory updates. Since it is a specific announcement about a major business development (engineering contract for a new facility) and does not fit the definitions for M&A (TAR), Financing (CAP), Director Dealing (DIRS), or specific financial reports, it is best classified as a general Regulatory Filing (RNS) or potentially a specific type of corporate announcement. Given the options, RNS serves as the best general category for significant, non-standard corporate news releases that aren't explicitly covered elsewhere. It is not a formal financial report, earnings release, or management discussion.
2014-03-05 French
GLOBAL BIOENERGIES partners with AUDI on drop-in biofuel
Regulatory Filings Classification · 100% confidence The document is a press release dated January 21, 2014, announcing a collaboration/alliance between Global Bioenergies and Audi regarding biofuel development. It details a business partnership, technological progress, and potential future share acquisition. This content does not fit the definitions for standard financial reports (10-K, IR, ER, MRQ), regulatory filings (DVA, DIRS), or meeting materials (AGM-R, DEF 14A). It is a general corporate announcement regarding strategic business development. Since it is a specific announcement about a partnership and not a general regulatory filing fallback (RNS), and it is not a transcript (CT), management discussion (MDA), or investor presentation (IP), the closest fit among the provided options for a significant corporate event announcement that isn't strictly financial reporting or governance is often categorized under general corporate news. However, given the options, this type of strategic business announcement is not explicitly covered. It is not a financing event (CAP), M&A (TAR), or dividend (DIV). Since it is a news release about a strategic alliance, and there is no specific 'Partnership Announcement' code, I must evaluate the remaining options. It is not a Director's Dealing (DIRS), Delisting (DLST), or Interest Rate Update (IRAT). It is not a formal report (AR, 10-K, IR). It is a news release disseminated via DGAP, which often falls under RNS if no other category fits. However, the content is highly specific about a business alliance. If we consider 'RPA' (Report Publication Announcement), this document is the announcement itself, not an announcement *about* another report. Given the lack of a specific 'Partnership' or 'Alliance' code, and recognizing this as a primary corporate news release, 'RNS' (Regulatory Filings - general/miscellaneous) is the most appropriate fallback for a non-standard, non-financial report press release.
2014-01-21 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.